The Enterprise Value as of December 2025 (TTM) for Cyfuse Biomedical K.K. (4892.T) is 4.16B

According to Cyfuse Biomedical K.K.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.16B. This represents a change of 6.42% compared to the average of 3.91B of the last 4 quarters.

Cyfuse Biomedical K.K. (4892.T) Historical Enterprise Value (quarterly & annually)

How has 4892.T Enterprise Value performed in the past?

The mean historical Enterprise Value of Cyfuse Biomedical K.K. over the last ten years is 2.97B. The current 4.16B Enterprise Value has changed 13.92% with respect to the historical average. Over the past ten years (40 quarters), 4892.T's Enterprise Value was at its highest in in the September 2022 quarter at 11.48B. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.48B.

Cyfuse Biomedical K.K. (4892.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cyfuse Biomedical K.K. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyfuse Biomedical K.K. (4892.T) Average Enterprise Value

How has 4892.T Enterprise Value performed in the past?

The current Enterprise Value of Cyfuse Biomedical K.K. (4892.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cyfuse Biomedical K.K. (4892.T) Enterprise Value vs. Peers

How is 4892.T’s Enterprise Value compared to its peers?

Cyfuse Biomedical K.K.’s Enterprise Value is greater than Modalis Therapeutics Corporation (1.42B), greater than SymBio Pharmaceuticals Limited (3.07B), greater than D. Western Therapeutics Institute, Inc. (3.94B), greater than PRISM BioLab Co.,LTD (2.57B), greater than Perseus Proteomics Inc. (2.86B), greater than KAINOS Laboratories, Inc. (2.62B), less than Nippon Chemiphar Co., Ltd. (15.06B), less than Precision System Science Co., Ltd. (4.56B), greater than WDB coco Co., Ltd. (2.83B), less than Delta-Fly Pharma, Inc. (6.07B),

Build a custom stock screener for Cyfuse Biomedical K.K. (4892.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyfuse Biomedical K.K. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyfuse Biomedical K.K. (4892.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyfuse Biomedical K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.